Suchergebnisse - "Cao, Lei"

PubPharm (12)

1

Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma

enthalten in: BMC cancer | 2024

von Liu, C. | Liu, F. | Nie, D. | +12

2

Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma

enthalten in: BMC cancer | 2024

von Liu, C. | Liu, F. | Nie, D. | +12

3

Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model

enthalten in: BMC cancer | 2023

von Duan, X. | Yang, B. | Zhao, C. | +3

4

miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer

enthalten in: BMC cancer | 2019

von Ge, P. | Cao, L. | Chen, X. | +2

5

miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer

enthalten in: BMC cancer | 2019

von Ge, P. | Cao, L. | Chen, X. | +2

6

miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer

enthalten in: BMC cancer | 2019

von Ge, P. | Cao, L. | Chen, X. | +2

7

XAB2 tagSNPs contribute to non-small cell lung cancer susceptibility in Chinese population

enthalten in: BMC cancer | 2015

von Pei, N. | Cao, L. | Liu, Y. | +5

8

XAB2 tagSNPs contribute to non-small cell lung cancer susceptibility in Chinese population

enthalten in: BMC cancer | 2015

von Pei, N. | Cao, L. | Liu, Y. | +5

9

XAB2 tagSNPs contribute to non-small cell lung cancer susceptibility in Chinese population

enthalten in: BMC cancer | 2015

von Pei, N. | Cao, L. | Liu, Y. | +5

10

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas

enthalten in: BMC cancer | 2015

von Gao, H. | Wang, F. | Lan, X. | +7